Connection

Alessandro Rambaldi to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Alessandro Rambaldi has written about Antibodies, Monoclonal.
Alessandro Rambaldi
Connection Strength
0.472
Antibodies, Monoclonal
  1. Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
    View in: PubMed
    Score: 0.229
  2. Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology. 2020 11; 225(6):152001.
    View in: PubMed
    Score: 0.216
  3. Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3. Blood. 2003 Jun 01; 101(11):4589-97.
    View in: PubMed
    Score: 0.016
  4. New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? Expert Opin Biol Ther. 2017 07; 17(7):821-836.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.